Trial Profile
Phase III trial of Hydroxyflutamide in prostate cancer.
Planning
Phase of Trial:
Phase III
Latest Information Update: 23 May 2018
At a glance
- Drugs Hydroxyflutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 23 May 2018 New trial record